Chronic Obstructive Pulmonary Disease, Part 2: A Review of Pharmacotherapy Options.

The Global Initiative for Chronic Obstructive Lung Disease Report provides guidance on prevention and management of chronic obstructive pulmonary disease (COPD), a pulmonary syndrome largely impacting older adults. Management of COPD in this patient population is often further complicated because of medication and disease state interactions. Pharmacists are in a unique position to impact patients with COPD through counseling on proper medication selection, disease state education, adherence, and proper inhaler technique.

Outcomes of Pharmacist-Conducted Admission Medication-Regimen Reviews in Long-term Care Facilities.

To assess the outcomes of pharmacist-completed aMRRs. The 2018 installation of the Improving Medicare Post-Acute Care Transformation (IMPACT) Act requires medication regimen reviews (aMRR) upon admission to long-term care (LTC) hospitals, nursing facilities, and inpatient-rehabilitation facilities. While the legislation does not require that pharmacists perform the reviews, pharmacists are aptly suited to add value to this practice.

Rates and Predictors of Physician-Recommended and Self-Reported Aspirin Use in 2015.

This study assesses the rate of providerrecommended aspirin use through the National Ambulatory Medical Care Survey (NAMCS) database versus self-reported aspirin use through the Behavioral Risk Factor Surveillance System (BRFSS) database and identifies factors that predict initiation of aspirin. This study provides insight into the rate of providerrecommended aspirin use versus self-reported aspirin use prior to the 2016 United States Preventive Service Task Force primary prevention recommendation update.
Retrospective, cross-sectional analysis of US population data obtained from medical records (NAMCS) and community-dwelling residents in four states (BRFSS) in 2015.